Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer
NCT01015521
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
50
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was not initiated as planned
Conditions
Breast Neoplasm
Interventions
DRUG:
Aminoflavone Prodrug
Sponsor
Tigris Pharmaceuticals